Earnings Feed
Start Free
CANCERVAX CORP·4

Feb 11, 2:46 PM ET

CANCERVAX CORP 4

4 · CANCERVAX CORP · Filed Feb 11, 2005

Insider Transaction Report

Form 4
Period: 2005-02-09
CANCERVAX CORPCNVX
VAN EPPS DENNIS E
VP, Research
Transactions
  • Award

    Common Stock

    2005-02-09+11,250→ 11,250 total
  • Award

    Stock Option (right to buy)

    2005-02-09+33,300→ 33,300 total
    Exercise: $7.93From: 2005-03-09Exp: 2015-02-08→ Common Stock (33,300 underlying)
  • Award

    Stock Option (right to buy)

    2005-02-09+33,750→ 33,750 total
    Exercise: $7.93Exp: 2015-02-08→ Common Stock (33,750 underlying)
Footnotes (5)
  • [F1]All shares shall be released from the Company's repurchase option upon the submission of a Biologics License Application for Canvaxin(TM).
  • [F2]The purchase price is equal to $0.00004.
  • [F3]1/48 vest monthly beginning on 03/09/2005.
  • [F4]Not applicable to this transaction.
  • [F5]11,250 shares vest upon the successful completion of all conformance lots required for submission of a Biologics License Application (BLA) for Canvaxin(TM) and 22,500 shares vest upon the approval of a BLA or equivalent marketing authorization for Canvaxin(TM) in the U.S. or E.U.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION